COVID-19 in nursing homes is stabilising The number of new nursing homes with COVID-19 patients is stabilising.
Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests
Rapid and accurate contact tracing required in the coming period Now that the Cabinet is relaxing the measures to combat the novel coronavirus step by step, people will go outside more frequently. The chance of the virus spreading again will then increase.
Clear impact achieved by national measures to combat the COVID-19 epidemic To monitor the effect of the measures against the spread of the novel coronavirus, the time when reported COVID-19 patients became ill was examined.
Blood spot test extended as of 1 January 2017 to include two more disorders As of 1 January 2017, the disorders alpha and beta thalassaemia will be added to the neonatal blood spot (‘heel prick’) screening programme.
Guus Velders in Nature's "Ten people that mattered this year" Researcher Dr Guus Velders of RIVM has made the Nature top-10 list of 2016. This means that, according to Nature, he was one of the 10 most influential scientists in 2016.
Playing sports on synthetic turf fields with rubber granulate is safe New research by the Dutch National Institute for Public Health and the Environment (RIVM) shows it is safe for people to play sports on synthetic turf fields with an infill of rubber granulate.
New version ReCiPe 2016 to determine environmental impact RIVM presents ReCiPe 2016 a new version of the in Europe commonly used life cycle impact model ReCiPe.
Slight increase in number of TB patients in 2015 After many years of decrease, the number of tuberculosis patients in the Netherlands rose again in 2015 by 6 percent.
No scientific evidence for effect front-of-pack labels Front-of-pack (FOP) nutrition labels can inform consumers about healthier products.